Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists. (Q35151533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Dan R Berlowitz

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Jennifer Anderson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Leonard M Pogach

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

Medical Care Research and Review

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

178-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12800683%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of a self-administered sensory testing tool to identify patients at risk of diabetes-related foot problems.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Why general practitioners and consultants change their clinical practice: a critical incident study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Thoracoscopic decortication as first-line therapy for pediatric parapneumonic empyema. A case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Specialty differences in the care of older patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Treating depression and anxiety in primary care. Closing the gap between knowledge and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

The cost to health plans of poor glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Identifying persons with diabetes using Medicare claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

The cost-effectiveness of intensive therapy for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting Physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Provider type and the receipt of general and diabetes-related preventive health services among patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Attitudes of primary care providers toward diabetes: barriers to guideline implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Potential short-term economic benefits of improved glycemic control: a managed care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Quality of life and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1077558703060002003